Viewing Study NCT05053802


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-06-17 @ 5:48 PM
Study NCT ID: NCT05053802
Status: RECRUITING
Last Update Posted: 2021-09-23
First Post: 2021-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Primary Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MPLC; Microwave ablation; PD-1 inhibitor View